|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.510 SEK | -0.40% |
|
+15.44% | -23.35% |
| 07-08 | Irlab board member James Gamgort buys shares for just under SEK 0.3m | FW |
| 06-30 | IRLAB Therapeutics AB Approves Election of Janne Backman as Vice Chairperson of the Board of Directors | CI |
EPS & Dividend: IRLAB Therapeutics AB
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.922 | 1 | -2.188 | -3.429 | -1.603 | -1.642 |
| Distribution rate | - | - | - | - | - | - |
| Reference price 2 | 42.000 | 44.000 | 38.300 | 7.500 | 10.750 | 1.970 |
| Nbr of stocks (in thousands) | 51,748 | 51,748 | 51,868 | 51,868 | 51,868 | 84,938 |
| Announcement Date | 4/15/21 | 4/8/22 | 4/29/24 | 4/29/24 | 4/25/25 | 4/29/26 |
1SEK in Million2SEK
Estimates
Past dividends: IRLAB Therapeutics AB
| 2026-06-08 | Ex-dividend date - 0.97854 SEK | 00:00 |
Upcoming Events: IRLAB Therapeutics AB
| 2026-08-26 | Earnings release | Q2 2026 | |
| 2026-11-13 | Earnings release | Q3 2026 | |
| 2027-02-11 | Earnings release | Annual 2026 | Day |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 0.58% | 0.64% | 33.6x | 20.62x | 12.3x | |
| 2.07% | 2.17% | 28.84x | - | - | |
| 2.81% | 2.94% | 32.43x | 366.15x | 7.35x | |
| 2.72% | 2.78% | 20.47x | 7.35x | 4.85x | |
| 2.8% | 2.92% | 22.14x | 6.24x | 5.72x | |
| 2.07% | 2.2% | 20.58x | 4.62x | 4.25x | |
| 2.45% | 2.59% | 25.76x | 18.01x | 6.78x | |
| 3.68% | 3.65% | 13.84x | 5.8x | 4.97x | |
| 2.47% | 2.56% | -41.37x | 8.23x | 5.93x | |
| Average | 2.41% | 2.49% | 17.37x | 54.63x | 6.52x | |
| Weighted average by Cap. | 1.98% | 2.07% | 24.45x | 64.49x | 8.09x |
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
